MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CLB — Core Laboratories Inc.
NYSECore Laboratories Inc.
$9.92
+0.16(+1.64%)
- O
- 9.77
- H
- 10.18
- L
- 9.74
- V
- 623.89K
⏱️ End-of-day dataAs of Oct 2, 2026
Core Laboratories Inc. Statistics
Total Valuation
| Market Cap | $476.74M |
| Enterprise Value | $476.87M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | 2026-08-10 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | 45.88M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 992.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 83,273.43 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -633,297.90 |
| EV / Sales | n/a |
| EV / EBITDA | 84,297.92 |
| EV / EBIT | 252,715.06 |
| EV / FCF | -514,981.98 |
Financial Position
| Current Ratio | 2.05 |
| Quick Ratio | n/a |
| Debt / Equity | 0.57 |
| Debt / EBITDA | 27.53 |
| Debt / FCF | -168.19 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | -0.27% |
| Return on Assets (ROA) | -0.13% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-0 |
| Employee Count | 3,300 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -$-251 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | -17.20% |
| 50-Day Moving Average | $11.57 |
| 200-Day Moving Average | $14.58 |
| Relative Strength Index (RSI) | 9.22 |
| Average Volume (20 Days) | 599,822 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | $15.96K |
| Operating Income | $1.24K |
| Pretax Income | -$1.00K |
| Net Income | -$-753 |
| EBITDA | $5.66K |
| EBIT | $1.89K |
| Loss Per Share | $-0.02 |
Balance Sheet
| Cash & Cash Equivalents | $22.82K |
| Total Debt | $155.75K |
| Net Cash | -$132.93K |
| Net Cash Per Share | $-0.00 |
| Equity (Book Value) | $275.14K |
| Book Value Per Share | $0.01 |
| Working Capital | $109.64K |
Cash Flow
| Operating Cash Flow | $5.72K |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -$-926 |
| FCF Per Share | $-0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
| Dividend Per Share | $0.04 |
| Dividend Yield | 0.40% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | 0.00% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |